|
1.
|
Bucky LP and Percec I: The science of
autologous fat grafting: views on current and future approaches to
neoadipogenesis. Aesthet Surg J. 28:313–321. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
2.
|
Hsu VM, Stransky CA, Bucky LP and Percec
I: Fat grafting’s past, present, and future: why adipose tissue is
emerging as a critical link to the advancement of regenerative
medicine. Aesthet Surg J. 32:892–899. 2012.
|
|
3.
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
4.
|
Trojahn Kølle SF, Oliveri RS, Glovinski
PV, Elberg JJ, Fischer-Nielsen A and Drzewiecki KT: Importance of
mesenchymal stem cells in autologous fat grafting: a systematic
review of existing studies. J Plast Surg Hand Surg. 46:59–68.
2012.PubMed/NCBI
|
|
5.
|
Philips BJ, Marra KG and Rubin JP: Adipose
stem cell-based soft tissue regeneration. Expert Opin Biol Ther.
12:155–163. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Watanabe M, Inukai K, Katagiri H, Awata T,
Oka Y and Katayama S: Regulation of PPAR gamma transcriptional
activity in 3T3-L1 adipocytes. Biochem Biophys Res Commun.
300:429–436. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Moldes M, Zuo Y, Morrison RF, et al:
Peroxisome-proliferator-activated receptor gamma suppresses
Wnt/beta-catenin signalling during adipogenesis. Biochem J.
376:607–613. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Wu Z, Rosen ED, Brun R, et al:
Cross-regulation of C/EBP alpha and PPAR gamma controls the
transcriptional pathway of adipogenesis and insulin sensitivity.
Mol Cell. 3:151–158. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Prusty D, Park BH, Davis KE and Farmer SR:
Activation of MEK/ERK signaling promotes adipogenesis by enhancing
peroxisome proliferator-activated receptor gamma (PPARgamma) and
C/EBPalpha gene expression during the differentiation of 3T3-L1
preadipocytes. J Biol Chem. 277:46226–46232. 2002. View Article : Google Scholar
|
|
10.
|
Crowe DL and Chandraratna RA: A retinoid X
receptor (RXR)-selective retinoid reveals that RXR-alpha is
potentially a therapeutic target in breast cancer cell lines, and
that it potentiates antiproliferative and apoptotic responses to
peroxisome proliferator-activated receptor ligands. Breast Cancer
Res. 6:R546–R555. 2004. View
Article : Google Scholar
|
|
11.
|
Yadav S, Anbalagan M, Shi Y, Wang F and
Wang H: Arsenic inhibits the adipogenic differentiation of
mesenchymal stem cells by down-regulating peroxisome
proliferator-activated receptor gamma and CCAAT enhancer-binding
proteins. Toxicol In Vitro. 27:211–219. 2013. View Article : Google Scholar
|
|
12.
|
Lo Furno D, Graziano AC, Caggia S, et al:
Decrease of apoptosis markers during adipogenic differentiation of
mesenchymal stem cells from human adipose tissue. Apoptosis.
18:578–588. 2013.PubMed/NCBI
|
|
13.
|
Dong YW, Wang XP and Wu K: Suppression of
pancreatic carcinoma growth by activating peroxisome
proliferator-activated receptor gamma involves angiogenesis
inhibition. World J Gastroenterol. 15:441–448. 2009. View Article : Google Scholar
|
|
14.
|
Fenner MH and Elstner E: Peroxisome
proliferator-activated receptor-gamma ligands for the treatment of
breast cancer. Expert Opin Investig Drugs. 14:557–568. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Pellikainen JM and Kosma VM: Activator
protein-2 in carcino-genesis with a special reference to breast
cancer - a mini review. Int J Cancer. 120:2061–2067. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Zuk PA, Zhu M, Mizuno H, et al:
Multilineage cells from human adipose tissue: implications for
cell-based therapies. Tissue Eng. 7:211–228. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wieczorek E, Reszka E, Gromadzinska J and
Wasowicz W: Genetic polymorphism of matrix metalloproteinases in
breast cancer. Neoplasma. 59:237–247. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Velinov N, Poptodorov G, Gabrovski N and
Gabrovski S: The role of matrix metalloproteinases in the tumor
growth and metastasis. Khirurgiia (Sofiia). 1:44–49. 2010.(In
Bulgarian).
|
|
19.
|
Kunigal S, Lakka SS, Gondi CS, Estes N and
Rao JS: RNAi-mediated downregulation of urokinase plasminogen
activator receptor and matrix metalloprotease-9 in human breast
cancer cells results in decreased tumor invasion, angiogenesis and
growth. Int J Cancer. 121:2307–2316. 2007. View Article : Google Scholar
|
|
20.
|
Lakka SS, Gondi CS, Dinh DH, et al:
Specific interference of urokinase-type plasminogen activator
receptor and matrix metal-loproteinase-9 gene expression induced by
double-stranded RNA results in decreased invasion, tumor growth,
and angiogenesis in gliomas. J Biol Chem. 280:21882–21892. 2005.
View Article : Google Scholar
|
|
21.
|
Tang L and Han X: The urokinase
plasminogen activator system in breast cancer invasion and
metastasis. Biomed Pharmacother. 67:179–182. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Holst-Hansen C, Johannessen B,
Hoyer-Hansen G, Romer J, Ellis V and Brunner N: Urokinase-type
plasminogen activation in three human breast cancer cell lines
correlates with their in vitro invasiveness. Clin Exp Metastasis.
14:297–307. 1996.PubMed/NCBI
|
|
23.
|
Wang XF, Zhou QM, Du J, Zhang H, Lu YY and
Su SB: Baicalin suppresses migration, invasion and metastasis of
breast cancer via p38MAPK signaling pathway. Anticancer Agents Med
Chem. 13:923–931. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Jezierska A and Motyl T: Matrix
metalloproteinase-2 involvement in breast cancer progression: a
mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
|
|
25.
|
Figueira RC, Gomes LR, Neto JS, Silva FC,
Silva ID and Sogayar C: Correlation between MMPs and their
inhibitors in breast cancer tumor tissue specimens and in cell
lines with different metastatic potential. BMC Cancer. 9:202009.
View Article : Google Scholar
|
|
26.
|
Perera RJ, Marcusson EG, Koo S, et al:
Identification of novel PPARgamma target genes in primary human
adipocytes. Gene. 369:90–99. 2006. View Article : Google Scholar : PubMed/NCBI
|
